While Holt's departure has led to the appointment of Aaron Berg, Amarin's (AMRN) President of the U.S. Business, as his successor, Vascepa's commercial update concerns a major national pharmacy ...

Generic drugmakers Hikma and Dr Reddy’s Laboratories have won a surprise victory in a US patent lawsuit that sets up early competition to cardiovascular drug Vascepa, Amarin’s only commercial ...

Amarin is on course to significantly increase the number of patients eligible for treatment with its purified fish oil drug Vascepa after an FDA advisory committee voted in favour of an expanded ...

IPE, which is the active ingredient in vascepa, significantly reduced the primary composite endpoint of cardiovascular events by 34% among patients with very well-controlled LDL-C. Elevated LDL-C ...

It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.